Cinctive Capital Management »

Miragen Therapeutics shares owned by Cinctive Capital Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Cinctive Capital Management from 13F filings

Historical chart of Cinctive Capital Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Cinctive Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Cinctive Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $715k 41k 17.51

More positions owned by Cinctive Capital Management

General Electric Com New Put Option (GE)
Ishares Tr Russell 2000 Etf Call Option (IWM)
AES Corporation (AES)
Impinj (PI)
Nextera Energy (NEE)
Vistra Energy (VST)
Starbucks Corporation Call Option (SBUX)
Humana Call Option (HUM)
Array Technologies Com Shs (ARRY)
Snowflake Cl A (SNOW)
Antero Midstream Corp antero midstream (AM)
Amazon (AMZN)
Jefferies Finl Group (JEF)
salesforce (CRM)
Western Digital (WDC)

View all positions for Cinctive Capital Management

Top funds holding Miragen Therapeutics

BlackRock
BlackRock
Deep Track Capital
VR Adviser
Fairmount Funds Management
Vanguard Group
Paradigm Biocapital Advisors
Perceptive Advisors
State Street Corporation
Commodore Capital
Novo A/S
Tang Capital Management
Alliancebernstein
Maverick Capital
Driehaus Capital Management

View all funds holding Miragen Therapeutics